Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zensark is a private technology services and AI solutions company with operations in India and the United States. The company is not a drug developer; instead, it builds and deploys software, AI, analytics, and product-development solutions, with a stated focus on healthtech and fintech. In healthcare, Zensark markets AI-enabled offerings for diagnostics support, predictive analytics, personalized treatment workflows, healthcare operations, and compliant patient-data handling. Its business appears to center on enterprise services, custom application development, and digital transformation rather than a therapeutic pipeline. For a biotech analyst, Zensark is best understood as a healthtech and applied AI vendor serving healthcare organizations rather than a biotech, pharma, or life sciences therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zensark.